Duovir N Tablet

Duovir N Tablet – Lamivudine (150mg) + Zidovudine (300mg) + Nevirapine (200mg)

Duovir N Tablet is a fixed-dose combination antiretroviral therapy containing Lamivudine 150mg, Zidovudine 300mg and Nevirapine 200mg, manufactured by Cipla Ltd. Lamivudine and Zidovudine are nucleoside reverse transcriptase inhibitors (NRTIs) while Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) – together they block HIV replication at different stages, lowering viral load and helping the immune system recover.

Key Features

• Triple-drug antiretroviral combination, made by Cipla
• Combines 2 NRTIs (Lamivudine, Zidovudine) with an NNRTI (Nevirapine)
• Helps lower HIV viral load and supports CD4 count recovery
• Simplifies combination ART into a single tablet
• Bottle of 30 tablets, Schedule H prescription drug

Composition

• Lamivudine (150mg) + Zidovudine (300mg) + Nevirapine (200mg)

Uses & Benefits

• Used as part of combination antiretroviral therapy for HIV-1 infection
• Helps reduce the amount of HIV virus in the blood
• Supports recovery and maintenance of immune (CD4) cell counts
• Reduces the risk of HIV-related complications and opportunistic infections
• Used under a structured ART regimen prescribed by a physician
• Helps reduce risk of mother-to-child HIV transmission when prescribed antenatally

Directions for Use

• Take exactly as prescribed by your physician
• Usually taken with or without food, at the same times each day
• Swallow the tablet whole with water
• Do not miss doses – consistent adherence is critical for ART effectiveness

Precautions

• Use only under the supervision of a qualified physician
• Inform your doctor of any kidney or liver conditions before starting treatment
• Regular monitoring of blood counts, liver and kidney function may be required
• Inform your healthcare provider about all other medications you are taking
• Consult your doctor before use during pregnancy or breastfeeding
• Do not skip or stop doses without medical advice, as this may lead to drug resistance

Storage

• Store below 30°C in a cool, dry place
• Keep out of reach of children
• Protect from excessive heat and moisture

Disclaimer

This is a Schedule H prescription medicine. This information is for general awareness and is not a substitute for professional medical advice, diagnosis or treatment. Do not start, stop or change the dose without consulting a qualified healthcare provider.